Literature DB >> 24095093

The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells.

Ya-Hui Ding1, Hong-Xia Fan, Jing Long, Quan Zhang, Yue Chen.   

Abstract

A series of guaianolide-type sesquiterpene lactones derivatives with arylation of α-methylene-γ-lactone moiety was synthesized using Heck reactions, and was evaluated for their activities against acute myelogenous leukemia (AML) cell line HL-60 and doxorubicin-resistant cell line HL-60/A. Although all compounds were significantly less active against HL-60 than the parent molecules, surprisingly, compounds 3a, 4c-4e, 5e, and 8d exhibited high potency against doxorubicin-resistant cell line HL-60/A (IC50=6.2-19 μM), and their activities against HL-60/A were comparable to that of their parent molecules. In view of their novel activities against HL-60/A, compound 5e with inhibitory activity against HL-60/A (IC50=6.2±0.5 μM) was selected for study its preliminary mechanism. The result reveals that compound 5e can obviously induce apoptosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myelogenous leukemia; Dehydrocostus lactone; Guaianolide-type sesquiterpene lactones; Micheliolide; Synthesis

Mesh:

Substances:

Year:  2013        PMID: 24095093     DOI: 10.1016/j.bmcl.2013.09.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer.

Authors:  Emilie Viennois; Bo Xiao; Saravanan Ayyadurai; Lixin Wang; Peng G Wang; Quan Zhang; Yue Chen; Didier Merlin
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

2.  Asymmetric total syntheses of megacerotonic acid and shimobashiric acid A.

Authors:  Scott W Krabbe; Jeffrey S Johnson
Journal:  Org Lett       Date:  2015-02-20       Impact factor: 6.005

3.  LiCl-promoted amination of β-methoxy amides (γ-lactones).

Authors:  Ru Zhao; Bing-Lin Zeng; Wen-Qiang Jia; Hong-Yi Zhao; Long-Ying Shen; Xiao-Jian Wang; Xian-Dao Pan
Journal:  RSC Adv       Date:  2020-09-21       Impact factor: 4.036

4.  Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.

Authors:  Yan Zhao; Si-jia Chen; Jian-cheng Wang; Hong-xin Niu; Qian-qian Jia; Xiao-wen Chen; Xiao-yan Du; Lu Lu; Bo Huang; Quan Zhang; Yue Chen; Hai-bo Long
Journal:  Oxid Med Cell Longev       Date:  2015-01-12       Impact factor: 6.543

5.  Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death.

Authors:  Yongsheng Jia; Liyan Zhou; Chen Tian; Yehui Shi; Chen Wang; Zhongsheng Tong
Journal:  Onco Targets Ther       Date:  2015-11-16       Impact factor: 4.147

6.  Micheliolide suppresses LPS-induced neuroinflammatory responses.

Authors:  Zhaomeng Sun; Guodong Li; Tanjun Tong; Jun Chen
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

7.  Modification of Natural Eudesmane Scaffolds via Mizoroki-Heck Reactions.

Authors:  Mohamed Zaki; Mohamed Akssira; Sabine Berteina-Raboin
Journal:  Molecules       Date:  2017-04-20       Impact factor: 4.411

8.  The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.

Authors:  Ning Xu; Zhongyan Hua; Gen Ba; Simeng Zhang; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  J Exp Clin Cancer Res       Date:  2019-03-08

9.  Synthesis and anticancer studies of Michael adducts and Heck arylation products of sesquiterpene lactones, zaluzanin D and zaluzanin C from Vernonia arborea.

Authors:  Tushar R Valkute; Eswar K Aratikatla; Neha A Gupta; S Ganga; Manas K Santra; Asish K Bhattacharya
Journal:  RSC Adv       Date:  2018-11-14       Impact factor: 4.036

10.  13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico.

Authors:  Douglas Kemboi; Moses K Langat; Xavier Siwe-Noundou; Tendamudzimu Tshiwawa; Rui W M Krause; Candace Davison; Christie Jane Smit; Jo-Anne de la Mare; Vuyelwa Jacqueline Tembu
Journal:  PLoS One       Date:  2022-08-23       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.